This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (32)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Michael Sandberg, MD; Carmelita U. Tuazon, MD; John N. Sheagren, MD

JAMA. 1975;232(11):1152-1154.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SEVERE neutropenia has been noted as a complication of the administration of penicillin and many of its derivatives but not of nafcillin. This may be a result of the less extensive use of nafcillin.¹ Lack of apparent hematologic complications with nafcillin has led some clinicians to conclude that it is a safer drug; however, it is probably best to consider nafcillin to be a member of the same family of drugs and likely, therefore, to have complications similar to those of other penicillins. To our knowledge, this is the first report of a case of neutropenia in a patient treated with nafcillin. Our findings tend to support the point of view that nafcillin may induce complications similar to those induced by other members of the penicillin family.

Report of a Case

A 24-year-old man with a history of intravenous drug use was admitted to the District of Columbia General . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Medicine, Infectious Diseases Unit, DC General Hospital, Howard Medical Service, Washington, DC.

Footnotes
Reprint requests to Infectious Diseases Unit, DC General Hospital, 19th and E streets SE, Washington, DC 20003 (Dr. Tuazon).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?